Flow of patients through the study.

<p>Flow of patients through the study.</p

Semen quality in patients receiving ART and mDRV/r.

<p>Semen quality in patients receiving ART and mDRV/r.</p

Seminal fluid values of the 21 patients who completed the study.

<p>Seminal fluid values of the 21 patients who completed the study.</p

ART scheme at V0.

<p>ART scheme at V0.</p

ROC curve of normal cytology <i>vs</i>. ≥AIN 1 and ≥ AIN 2 lesions.

<p>ROC curve of normal cytology <i>vs</i>. ≥AIN 1 and ≥ AIN 2 lesions.</p

ROC curve of HR-HPV-negative and normal cytology <i>vs</i>. normal histology.

<p>ROC curve of HR-HPV-negative and normal cytology <i>vs</i>. normal histology.</p

Degree of correlation between anal cytology and HR-HPV PCR, with histology

<p>Kappa: Kappa index; p* significance.</p

General description of the patient study sample.

<p>HCV: hepatitis C virus infection; HBV: hepatitis B virus infection; EXIVDA: ex-intravenous drug abuser; STD: sexually transmitted disease; VL: HIV viral load; IQR: interquartile range; SD: standard deviation</p><p>General description of the patient study sample.</p

Risk factors associated with the appearance of HSIL in anoscopy.

<p>MSM HIV-positive: men who have sex with men and are HIV-positive; LTI: latent tuberculosis infection; HCV: hepatitis C virus; HBV: hepatitis B virus; HPV: human papilloma virus; EXIVDA: ex-intravenous drug abuser; VL: HIV viral load; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV</p><p>Results of univariate analyses.</p

Risk factors associated with the appearance of lesions ≥AIN2. Univariate analysis.

<p>MSM-HIV-positive: males who have sex with males HIV-positive, VL: viral load; HCV: hepatitis C virus; HBV: hepatitis B virus; HPV: human papilloma virus; VL: HIV viral load; HR-HPV: high risk human papilloma virus; LR-HPV: low risk human papilloma virus; IQR: inter-quartile range.</p